FDA Turns Down ATTR Cardiomyopathy Drug

Decision cites insufficient evidence of clinical meaningfulness

Related Keywords

Stanford University ,California ,United States ,New York ,Columbia University ,America ,Jeff Teuteberg ,Mathew Maurer ,Heart Failure Society Of America ,Stanford University Health Care ,Drugmaker Alnylam Pharmaceuticals ,Alnylam Pharmaceuticals ,Heart Failure Society ,Failure Society ,